Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott Laboratories : Tiësto Teams Up with Music Saves Lives® and Abbott to Encourage Young People to Donate Blood

11/12/2013 | 11:00am EST

Abbott Park, Illinois (NYSE: ABT) - With advances in medical treatments and an aging population, the demand for donated blood continues, as fewer people are becoming lifelong donors.1In an effort to raise awareness about blood donation and encourage young adults to become repeat blood donors, Music Saves Lives® and Abbott are announcing a special opportunity to meet legendary DJ and producer Tiësto.

Music Saves Lives partners with musicians and entertainers like Tiësto to encourage young adults to participate in community blood drives and then thanks donors by giving them special access to music and entertainment. Winners from across the United States will be able to attend one of Tiësto's concerts on Nov. 22 or Nov. 23, 2013, at Echostage in Washington, DC. For additional details about how to enter the giveaway, please visit www.musicsaveslives.org.

"Blood is a vital resource that cannot be manufactured, and it's only available through the generosity of donors," said Tiësto. "I'm getting involved to help spread the message - so that my great fans will take notice and step up to donate blood to help those in need."

It is estimated that every two seconds someone in the United States needs blood.2 Often this means that hospitals and clinics face the challenge of providing enough blood to patients.1,2 Earlier this year, Abbott teamed up with the non-profit organization Music Saves Livesto encourage young adults to consider becoming life-long donors through the Very Important Donor (VID) Club program.

"Blood transfusion is a gift that helps save millions of lives every year," said Brian Blaser, executive vice president, Diagnostics Products, Abbott. "Abbott is proud to work with Tiësto and Music Saves Lives to raise awareness about blood donation and to help ensure that we have an ample blood supply."

To find an upcoming blood drive in your area, please visit one of the following websites: American Red Cross, America's Blood Centers, or AABB. To learn more about the importance of donating blood, please click here. To learn more about Tiësto and his award-winning work, please click here.

About the Very Important Donor Club

The Very Important Donor Club (#DonorsClub) encourages people to make a commitment to donating blood a specific number of times each year. By signing up, members learn more about how their donation will make a difference and how some of their favorite musicians and entertainers are supporting this effort. Very Important Donor Club members who commit to donate blood at least one time per year may earn special benefits at Music Saves Lives events.

About Music Saves Lives

Music Saves Lives is a 501(c) 3) organization with the mission to educate about important life-saving causes and to use all forms of music and entertainment to motivate and deliver this message. Music Saves Lives started its mission to educate youth about the importance of blood donation and the bone marrow registry, encouraging participation and commitment to action in a life-saving way. These simple commitments all connect back to strengthening the community. Visit www.musicsaveslives.org to learn more.

About Abbott's Commitment to Blood Screening

Abbott is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics. With a more than 40-year commitment to continuous improvements to blood screening technologies, Abbott is a leader in helping to ensure the safety of the world's blood supply and is dedicated to advancing the science of blood transfusion.

About Abbott

Abbott (NYSE: ABT) is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

distributed by

© Publicnow 2013
All news about ABBOTT LABORATORIES
06:00aDonors bet a U.S. firm could transform disease testing in Africa. Then COVID-..
RE
02/24SENSOR PATCH MARKET SIZE, TRENDS AND : Abbott Laboratories, Irhythm Technologies..
AQ
02/22ABBOTT LABORATORIES  : Declares 389th consecutive quarterly dividend
AQ
02/19ABBOTT LABORATORIES  : Change in Directors or Principal Officers, Amendments to ..
AQ
02/19ABBOTT LABORATORIES  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
02/19ABBOTT LABORATORIES  : Declares Quarterly Dividend of $0.45 a Share; Payable May..
MT
02/19ABBOTT  : Declares 389th Consecutive Quarterly Dividend
PR
02/19ABBOTT LABORATORIES  : SEC Filing 8K
CO
02/18INSIDER TRENDS : Abbott Laboratories Insider Sells Shares for Tax Slowing 90-Day..
MT
02/18INSIDER TRENDS : Abbott Laboratories Insider Makes Tax Sale Interrupting 90-Day ..
MT
More news
Financials (USD)
Sales 2021 42 318 M - -
Net income 2021 7 394 M - -
Net Debt 2021 8 762 M - -
P/E ratio 2021 30,1x
Yield 2021 1,31%
Capitalization 216 B 216 B -
EV / Sales 2021 5,32x
EV / Sales 2022 5,23x
Nbr of Employees 109 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 133,39 $
Last Close Price 122,21 $
Spread / Highest target 29,3%
Spread / Average Target 9,15%
Spread / Lowest Target -23,9%
EPS Revisions
Managers and Directors
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert E. Funck Chief Financial Officer & Executive Vice President
Miles D. White Executive Chairman
Roxanne Schuh Austin Independent Director
Glenn Fletcher Tilton Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES9.40%212 194
MEDTRONIC PLC-0.15%157 614
BECTON, DICKINSON AND COMPANY-1.66%70 069
ALIGN TECHNOLOGY, INC.5.75%44 717
HOYA CORPORATION-13.95%41 829
SARTORIUS STEDIM BIOTECH25.41%40 374